EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

IgA Nephropathy With Membranoproliferative Pattern and Resistance to Immunosuppressive Therapy in Two Patients With Cofactor I Pathogenic Variant

Tommaso Mazzierli iD, Pamela Gallo, Costanza Giuliani, Elisabetta Pelo, Pietro Dattolo, Chiara Somma

Nephrology · 2025

DOI: 10.1111/nep.70092 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Nephrology, 2025. Verfasst von Tommaso Mazzierli und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology and Dialysis, Santa Maria Annunziata Hospital, Florence, Italy. Hauptthemen laut MEDLINE: Drug Resistance, Glomerulonephritis, IGA, Glomerulonephritis, Membranoproliferative, Immunosuppressive Agents. Die Arbeit nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Complement system (CS) overactivation is one of the main causes of kidney damage in IgA nephropathy (IgAN), and it mainly involves the alternative pathway (AP). Additionally, pathogenic complement variants in CS‐related genes are reported in IgAN with associated thrombotic microangiopathy (TMA). Here we report two patients with IgAN presenting membranoproliferative pattern, isolated C3 hypocomplementemia, resistance to multiple lines of immunosuppressive therapy, familiarity for proteinuric chronic kidney disease and pathogenic rare variants in cofactor I (CFI). To the best of our knowledge, no other cases of IgAN patients with a similar phenotype and genotype were previously reported in the literature. This work highlights the essential role of deep phenotyping and genotyping in providing tailored treatment strategies in IgAN patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug ResistanceGlomerulonephritis, IGAGlomerulonephritis, MembranoproliferativeImmunosuppressive AgentsHumansComplement C3PhenotypeTreatment OutcomeComplement Factor I

Stichwörter der Autor:innen

IgA nephropathycofactor Icomplementgenetic

Substanzen

CFI protein, humanComplement C3Immunosuppressive AgentsComplement Factor I

Autor:innen und Institutionen

  • Department of Nephrology and Dialysis, Santa Maria Annunziata Hospital, Florence, Italy.
  • Department of Biomedical Experimental and Clinical Sciences "Mario Serio", University of Florence, Florence, Italy.
  • Diagnostica Genetica, Careggi University Hospital, Florence, Italy.

ORCID-Profile: Tommaso Mazzierli

Zitieren

APA

Mazzierli, T., Gallo, P., Giuliani, C., Pelo, E., Dattolo, P., & Somma, C. (2025). IgA Nephropathy With Membranoproliferative Pattern and Resistance to Immunosuppressive Therapy in Two Patients With Cofactor I Pathogenic Variant. Nephrology. https://doi.org/10.1111/nep.70092

Vancouver

Mazzierli T, Gallo P, Giuliani C, Pelo E, Dattolo P, Somma C. IgA Nephropathy With Membranoproliferative Pattern and Resistance to Immunosuppressive Therapy in Two Patients With Cofactor I Pathogenic Variant. Nephrology. 2025. doi:10.1111/nep.70092

BibTeX
@article{Mazzierli2025,
  author = {Mazzierli, Tommaso and Gallo, Pamela and Giuliani, Costanza and Pelo, Elisabetta and Dattolo, Pietro and Somma, Chiara},
  title = {IgA Nephropathy With Membranoproliferative Pattern and Resistance to Immunosuppressive Therapy in Two Patients With Cofactor I Pathogenic Variant},
  journal = {Nephrology},
  year = {2025},
  doi = {10.1111/nep.70092}
}
Kostenlos starten →